Rhythm Pharmaceuticals (RYTM) Change in Cash (2016 - 2026)

Rhythm Pharmaceuticals (RYTM) has 11 years of Change in Cash data on file, last reported at $7.9 million in Q1 2026.

• On a quarterly basis, Change in Cash fell 53.33% year-over-year to $7.9 million in Q1 2026; TTM through Mar 2026 was -$43.8 million, a 183.2% decrease from a year earlier, with the FY2025 full-year figure at -$34.8 million, down 219.14% from the prior year.
• Change in Cash for Q1 2026 stood at $7.9 million, up from $2.1 million in the prior quarter.
• Over the last five years, Change in Cash for RYTM reached as high as $108.2 million in Q2 2024 and fell as low as -$114.1 million in Q3 2024.
• Historically, Change in Cash has averaged $186000.0 across 5 years, with a median of $6.0 million in 2023.
• Across the five-year window, Change in Cash slumped 193.4% in 2023 and surged 1697.11% in 2024, its largest moves.
• Year by year, Change in Cash stood at -$57.4 million in 2022, then surged by 92.14% to -$4.5 million in 2023, then soared by 1022.38% to $41.6 million in 2024, then slumped by 95.02% to $2.1 million in 2025, then soared by 281.63% to $7.9 million in 2026.
• Per Business Quant data, the three most recent Change in Cash figures were $7.9 million in Q1 2026, $2.1 million in Q4 2025, and -$83.4 million in Q3 2025.